TIBER CREEK GROUP

Lobbying for PHRMA

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $110,000.00 income · posted Jul 19, 2026

Bills named in this filing 1

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Pricing Reform.

Trade (domestic/foreign)

Issues related to intellectual property protections; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410); Issues related to immunization policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.